Goldman Sachs Provides Color on Biotechnology

Goldman Sachs provided color on the biotechnology sector. Its top picks are Alexion Pharmaceuticals ALXN and Vertex Pharmaceuticals VRTX. At the same time, the rating agency has a Sell rating on Amgen AMGN. On Tuesday, AMGN closed the day at $56.90. Its shares lost 0.21% of their value in today's pre-market trading to stand around $57.02. At the same time, ALXN added 0.08% to its value on Tuesday to end the day at $50.41, while VRTX rose 2.27% to end the day at $51.41.